跳至主要内容
临床试验/CTRI/2012/09/002954
CTRI/2012/09/002954已完成2 期

An Open Label, Prospective Clinical Study to Evaluate the Efficacy and Safety ofTLPL/AY/01/2008 in the Management of Functional Constipation - None

Tulip Lab Pvt Ltd0 个研究点目标入组 25 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects presenting with two or more of the following for the last 3 months with symptom onset at least 6 months prior to diagnosis
  • a. Straining during at least 25% of defecations
  • b. Lumpy or hard stools at least 25% of defecations
  • c. Sensation of incomplete evacuation at least 25% of defecations
  • d. Sensation of anorectal obstruction/blockage at least 25% of defecations
  • e. Manual maneuvers to facilitate at least 25% of defecations e.g., digital evacuation, support of the pelvic floor
  • f. Fewer than three defecations per week
  • 2. Subjects in whom loose stools are rarely present without the use of laxatives
  • 3. Subjects not meeting Rome diagnostic criteria for IBS
  • 4. Subjects in the age group of 18 to 70 years
  • 5. Subjects having stool form between 1 to 3 on the Bristol Stool Form Scale
  • 6. Willingness to sign informed consent document and to comply with the protocol.

排除标准

  • 1. Subjects with diagnosed colonic inertia.
  • 2. Subjects who have recently undergone abdominal surgery
  • 3. Subjects with history of anorectal surgery.
  • 4. Subjects having other functional gastrointestinal disorders other than Functional constipation i.e. IBS, Belching disorders etc.
  • 5. Subjects diagnosed with structural abnormalities, like:
  • i.Anorectal: rectal prolapse, rectocele, rectal intussusceptions,
  • anorectal stricture, solitary rectal ulcer syndrome
  • ii.Perineal descent
  • iii.Colonic or rectal mass or tumor with obstruction e.g.
  • adenocarcinoma
  • iv.Colonic stricture: radiation, ischemia, diveticulosis
  • v.Intestinal obstruction
  • 6. Subjects with serious uncontrolled & diagnosed systemic ailments like HIV, DM and Tuberculosis.
  • 7. Subjects with renal or liver dysfunction
  • 8. Subjects with diagnosed neurological problems like,
  • vi.Parkinsons disease
  • vii.Multiple sclerosis
  • viii.Sacral nerve damage for example prior pelvic surgery, tumor
  • ix.Paraplegia
  • x.Autonomic neuropathy
  • 9. Pregnant or lactating females
  • 10. Subjects not willing to sign informed consent form
  • 11. Subjects allergic or atopic to any of the ingredients of the study medication

研究者

发起方
Tulip Lab Pvt Ltd

相似试验